EAM
GILD icon

Eukles Asset Management’s Gilead Sciences GILD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.51M Sell
13,584
-326
-2% -$36.1K 0.62% 52
2025
Q1
$1.56M Sell
13,910
-116
-0.8% -$13K 0.68% 51
2024
Q4
$1.3M Sell
14,026
-159
-1% -$14.7K 0.55% 57
2024
Q3
$1.19M Sell
14,185
-251
-2% -$21K 0.48% 58
2024
Q2
$990K Sell
14,436
-171
-1% -$11.7K 0.43% 57
2024
Q1
$1.07M Buy
14,607
+389
+3% +$28.5K 0.47% 58
2023
Q4
$1.15M Sell
14,218
-469
-3% -$38K 0.54% 55
2023
Q3
$1.1M Buy
14,687
+85
+0.6% +$6.37K 0.58% 53
2023
Q2
$1.13M Buy
14,602
+64
+0.4% +$4.93K 0.58% 52
2023
Q1
$1.21M Sell
14,538
-61
-0.4% -$5.06K 0.66% 52
2022
Q4
$1.25M Buy
14,599
+724
+5% +$62.1K 0.73% 50
2022
Q3
$856K Buy
13,875
+298
+2% +$18.4K 0.56% 58
2022
Q2
$839K Buy
13,577
+150
+1% +$9.27K 0.53% 57
2022
Q1
$798K Sell
13,427
-1,113
-8% -$66.1K 0.43% 60
2021
Q4
$1.06M Sell
14,540
-304
-2% -$22.1K 0.51% 58
2021
Q3
$1.04M Sell
14,844
-41
-0.3% -$2.86K 0.57% 55
2021
Q2
$1.03M Buy
14,885
+790
+6% +$54.4K 0.57% 57
2021
Q1
$911K Buy
14,095
+97
+0.7% +$6.27K 0.59% 56
2020
Q4
$816K Buy
13,998
+332
+2% +$19.4K 0.56% 55
2020
Q3
$864K Buy
13,666
+128
+0.9% +$8.09K 0.67% 55
2020
Q2
$1.04M Buy
13,538
+895
+7% +$68.8K 0.89% 45
2020
Q1
$945K Sell
12,643
-640
-5% -$47.8K 0.98% 43
2019
Q4
$863K Sell
13,283
-162
-1% -$10.5K 0.7% 52
2019
Q3
$852K Sell
13,445
-43
-0.3% -$2.73K 0.74% 53
2019
Q2
$911K Sell
13,488
-59
-0.4% -$3.99K 0.79% 52
2019
Q1
$881K Buy
13,547
+67
+0.5% +$4.36K 0.8% 52
2018
Q4
$843K Buy
+13,480
New +$843K 0.88% 50